01 6Briviact
Main Therapeutic Indication : CNS & Anesthesia
Currency : USD
2019 Revenue in Millions : 241
2018 Revenue in Millions : 155
Growth (%) : 56
Main Therapeutic Indication : CNS & Anesthesia
Currency : USD
2020 Revenue in Millions : 348
2019 Revenue in Millions : 267
Growth (%) : 30
Main Therapeutic Indication : Neurology
Currency : USD
2021 Revenue in Millions : 391
2020 Revenue in Millions : 348
Growth (%) : 23
Main Therapeutic Indication : Neurology
Currency : USD
2022 Revenue in Millions : 517
2021 Revenue in Millions : 391
Growth (%) : 32
Main Therapeutic Indication : Neurology
Currency : USD
2023 Revenue in Millions : 622
2022 Revenue in Millions : 517
Growth (%) : -16
Main Therapeutic Indication : Neurological/Mental Disorders
Currency : USD
2018 Revenue in Millions : 160
2017 Revenue in Millions : 97
Growth (%) : 65%
LOOKING FOR A SUPPLIER?